Skip to main content
Premium Trial:

Request an Annual Quote

PamGene and Jerini Peptide Technologies Jointly Offer Products

NEW YORK, June 22 (GenomeWeb News) - PamGene International and Jerini Peptide Technologies will jointly offer their microarray and peptide products for kinase studies, the companies said today.


Under the agreement, PamGene and Jerini will offer PamGene's 96-well microarray platform and Jerini's kinase peptide substrates.


Jerini Peptide Technologies of Berlin, a division of Jerini, provides peptide-based services and products. PamGene International, based in 's-Hertogenbosch, the Netherlands, offers three-dimensional microarray technology.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.